Research ArticleCancer

Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy

See allHide authors and affiliations

Science Translational Medicine  20 Mar 2019:
Vol. 11, Issue 484, eaar5012
DOI: 10.1126/scitranslmed.aar5012

Log in to view full text

Log in through your institution

Log in through your institution

Navigate This Article